Investor FAQs

INVESTORS & MEDIA

INVESTORS
& MEDIA

Investor FAQs

Show All

We started trading publicly in April 1991.

Our corporate headquarters and research laboratories are located in Tarrytown, NY, our large-scale manufacturing facilities are located in Rensselaer, NY and Limerick, Ireland, our satellite offices are located in Sleepy Hollow, NY and Basking Ridge, NJ, and our European business offices are located in Dublin, Ireland and London, United Kingdom.

As of December 2019, we have over 8,000 regular employees

Shares of our common stock are listed on The NASDAQ Global Select Market under the symbol REGN.

The most up-to-date number of shares outstanding can be found on the front page of our most recent form 10-Q, which can be found at the Financial Information section on our Investor Relations website

You can purchase stock in our company through a registered brokerage or stock purchase service provider of your choice. You cannot buy Regeneron stock directly from the company.

You will need to contact the broker from whom you purchased your shares.

American Stock Transfer & Trust
6201 15th Avenue
Brooklyn, New York 11219
(800) 937-5449

No, we have never paid a cash dividend nor do we expect to pay any dividends in the foreseeable future.

We typically report quarterly financial results and hold a related conference call around 40 days after the final day of the quarter. You can access our earnings press releases in the News section, and the Earnings Call webcasts in the Events section of our Investor Relations website.

Our Annual Meeting of Stockholders is held each June in Tarrytown, New York. An announcement with exact date, time and location will be posted on our website at least 70 days before the event each year.

Proxy statements are available through the Financial Information section of our Investor Relations website under the heading "SEC Filings."

PricewaterhouseCoopers LLC

If you can't find the information you're looking for on our Web site, please feel free to contact Investor Relations at (914) 847-7741. 

Please visit the Financial Information section of the Investor Relations website or refer to the most recent 10-Q or 10-K report under the heading "SEC Filings."

Please visit the Investor Relations website and choose the "Email Alerts" tab to be added to the Regeneron distribution list.